Literature DB >> 9161713

Inhibition of DNA primase by sphingosine and its analogues parallels with their growth suppression of cultured human leukemic cells.

K Tamiya-Koizumi1, T Murate, M Suzuki, C M Simbulan, M Nakagawa, M Takemura, K Furuta, S Izuta, S Yoshida.   

Abstract

Sphingosine is a potent inhibitor of a mammalian DNA primase in vitro (Simbulan et al., Biochemistry 33, 9007-9012, 1994). Here we measured the inhibition of DNA primase in vitro by 9 sphingosine-analogues with respect to RNA primer synthesis and DNA primase-dependent DNA synthesis, and their potencies of inhibition in vitro were compared with their in vivo effects on human leukemic cells. Sphingosine, phytosphingosine and N, N-dimethylsphingosine strongly inhibited the activity of purified calf thymus DNA primase, and also inhibited the growth of human leukemic cell line HL-60, exerting strong cytotoxicity. Dihydrosphingosine and cis-sphingosine, which showed more subtle inhibition of DNA primase in vitro, moderately inhibited the cell growth in vivo and caused cell death. In contrast, N-acyl-, N-octyl-, and N-acetylsphingosine (ceramides) showing little inhibition of DNA primase suppressed cell growth only slightly. HL 60 cell was arrested at Go/G1 phase by exogenously added sphingosine. From these results, it is suggested that DNA primase is one of targets of sphingosine, an effector molecule in apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9161713     DOI: 10.1080/15216549700202271

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  11 in total

1.  Purified canola lutein selectively inhibits specific isoforms of mammalian DNA polymerases and reduces inflammatory response.

Authors:  Sho Horie; Chiaki Okuda; Takatoshi Yamashita; Kenichi Watanabe; Kouji Kuramochi; Masashi Hosokawa; Toshifumi Takeuchi; Makiko Kakuda; Kazuo Miyashita; Fumio Sugawara; Hiromi Yoshida; Yoshiyuki Mizushina
Journal:  Lipids       Date:  2010-07-29       Impact factor: 1.880

2.  Inhibitory effects of cholesterol derivatives on DNA polymerase and topoisomerase activities, and human cancer cell growth.

Authors:  Chisato Ishimaru; Yuko Yonezawa; Isoko Kuriyama; Masayuki Nishida; Hiromi Yoshida; Yoshiyuki Mizushina
Journal:  Lipids       Date:  2008-01-24       Impact factor: 1.880

3.  Inhibition of DNA primase and induction of apoptosis by 3,3'-diethyl-9-methylthia-carbocyanine iodide in hepatocellular carcinoma BEL-7402 cells.

Authors:  Zhi-Ming Li; Zong-Chao Liu; Zhong-Zhen Guan; Xiao-Feng Zhu; Jun-Min Zhou; Bing-Fen Xie; Gong-Kan Feng; Zhen-Yu Zhu; Wen-Qi Jiang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

4.  Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.

Authors:  Peng Gao; Yuri K Peterson; Ryan A Smith; Charles D Smith
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

5.  Anti-cancer gallotannin penta-O-galloyl-beta-D-glucose is a nanomolar inhibitor of select mammalian DNA polymerases.

Authors:  Yoshiyuki Mizushina; Jinhui Zhang; Angelo Pugliese; Sung-Hoon Kim; Junxuan Lü
Journal:  Biochem Pharmacol       Date:  2010-06-26       Impact factor: 6.100

Review 6.  Structures to complement the archaeo-eukaryotic primases catalytic cycle description: What's next?

Authors:  Julien Boudet; Jean-Christophe Devillier; Frédéric H-T Allain; Georg Lipps
Journal:  Comput Struct Biotechnol J       Date:  2015-05-02       Impact factor: 7.271

Review 7.  Exploring Sphingolipid Implications in Neurodegeneration.

Authors:  Alice V Alessenko; Elisabetta Albi
Journal:  Front Neurol       Date:  2020-05-21       Impact factor: 4.003

8.  3-O-methylfunicone, a selective inhibitor of mammalian Y-family DNA polymerases from an Australian sea salt fungal strain.

Authors:  Yoshiyuki Mizushina; Hirohisa Motoshima; Yasuhiro Yamaguchi; Toshifumi Takeuchi; Ken Hirano; Fumio Sugawara; Hiromi Yoshida
Journal:  Mar Drugs       Date:  2009-11-23       Impact factor: 5.118

9.  Anti-tumor effects of novel 5-O-acyl plumbagins based on the inhibition of mammalian DNA replicative polymerase activity.

Authors:  Moe Kawamura; Isoko Kuriyama; Sayako Maruo; Kouji Kuramochi; Kazunori Tsubaki; Hiromi Yoshida; Yoshiyuki Mizushina
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

Review 10.  DnaG Primase-A Target for the Development of Novel Antibacterial Agents.

Authors:  Stefan Ilic; Shira Cohen; Meenakshi Singh; Benjamin Tam; Adi Dayan; Barak Akabayov
Journal:  Antibiotics (Basel)       Date:  2018-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.